doi: 10.1016/j.cmet.2021.12.010 Summary Keywords GIP, GLP-1, obesity, weight loss, tirzepatide, GLP-1R agonists, GIP receptor agonists, Citation Zaffina I, Pelle MC, Armentaro G, Giofr F, Cassano V, Sciacqua A and Arturi F (2023) Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
Some metabolic effects may begin earlier, but the most meaningful weight loss results in trials developed over several months , especially as participants progressed through dose escalation and reached higher maintenance doses
GLP-1 tambin suprime el glucagn, una hormona que eleva el azcar en sangre, especialmente cuando ya se encuentra en concentraciones demasiado altas
Drinking water with your injection can help reduce irritation at the injection site
Without such a solution, powdered medications cannot be given to patients effectively